Life settlement returns are calculated as an internal rate of return (IRR) based on the difference between what the investor pays for a policy plus ongoing premiums, and the death benefit received when the insured passes away. Historical academic and industry data place average annualized returns in the 8–12% range, with meaningful variance driven by actuarial life expectancy accuracy. When the insured passes earlier than projected, IRRs can exceed 15–20%. When the insured lives longer than projected, IRRs compress — and in extended longevity scenarios, returns can fall to low single digits or even turn negative if premium reserves are insufficient. There are no guaranteed returns in this asset class.
This is probably the most important article I've written in this series, because returns are the first question every investor asks and the one most sales materials handle poorly. The math on life settlements isn't complicated once you see it laid out, but the industry tends to market the good-case scenario and leave the other two at the bottom of the disclosure. I want to walk you through all three — the early-death scenario, the baseline scenario where the insured passes at the projected LE, and the extended longevity scenario — so you can actually model what your return looks like under each one before committing capital to a specific policy.
The return formula — what drives IRR
A life settlement return is conceptually simple: you pay money in, you pay premiums over a hold period, and you collect the death benefit when the insured passes away. The IRR is the annualized rate that makes the net present value of those cash flows equal to zero. Here's the formula expressed more practically, variable by variable:
Every variable in that equation is known at closing except one: the time of maturity. And because the death benefit is discounted exponentially the longer you hold the policy, even modest changes to the time of maturity produce dramatic changes in IRR. A policy that matures one year earlier than projected can see its IRR jump by 200–400 basis points. A policy that matures two years later than projected can see its IRR fall by 300–500 basis points. That asymmetry is the whole reason life settlements need actuarial underwriting — to get the projected time of maturity as accurate as possible before capital is committed.
Why the projection matters more than the face value
New investors tend to focus on face value — a $1M policy feels bigger than a $500K policy, so it must be "better." That's backwards. The face value determines the scale of the eventual payout, but the economic return is determined by purchase price relative to face value (your entry multiple) and the accuracy of the life expectancy projection. I've seen investors pay 25% of face for a well-priced policy on an insured with a tight LE range and earn mid-teen IRRs. I've seen other investors pay 22% of face for what looked like a better deal and earn 4% because the LE was 36 months wider than the insured's actual remaining life experience ended up being. The sticker price isn't the return. The underwriting is.
Three scenarios every investor should model
Before I commit any capital to a specific policy, I run three IRR scenarios in a spreadsheet. This is the framework I recommend to every investor new to the asset class. All three use the same purchase price and premium schedule — only the time of maturity changes. The point of running all three is to see what your capital does in each outcome so you're not relying on the baseline to justify the deployment.
Fewer premiums paid, death benefit received sooner. Return compounds favorably. Not something to pursue morally — it's just the actuarial asymmetry of the asset class.
The base-case return that most industry materials reference. Achievable when LE underwriting is accurate and the policy is priced competitively. Plan and price against this scenario.
More premiums paid than expected, death benefit received later. IRR compresses significantly. Extreme cases can drop below zero if premium reserves are exhausted before maturity.
If the baseline IRR isn't compelling on its own, the early-maturity upside isn't enough to make the deal work either. Strong LE underwriting and tight dispersion between the LE projection and realistic outcome ranges are what make the math reliable. I never recommend a policy to an investor based primarily on the early-maturity scenario — that's selling hope, not analysis. The baseline has to stand on its own, and the extended longevity scenario has to be survivable.
Browse vetted policies with full IRR projections
Every listing on the HYV platform includes the baseline IRR plus sensitivity analysis under both faster and slower maturity scenarios — so you see all three outcomes before committing capital.
Browse ListingsHistorical return data from LISA and academic research
Return expectations should be grounded in actual data, not marketing claims. Here's what the available evidence says about life settlement returns when measured at scale across many policies and many years.
LISA Market Data — aggregate transaction-level indicators
The LISA 2024 Market Data Collection Survey reported 2,699 secondary market transactions completed by LISA-licensed providers in 2024, totaling $601M in aggregate transaction value delivered to sellers. That's transaction data — not investor IRR data directly. But the 6.5× average multiple over cash surrender value is a proxy for how much economic value the secondary market is creating relative to alternative outcomes for the seller. The bigger that multiple, the more room there is on the buy-side for investor returns.
Academic research — empirical IRR studies
Published academic research has analyzed life settlement IRR data across large transaction samples. A study published in the Journal of International Financial Markets, Institutions and Money — based on data from one of the market's leading providers — analyzed IRRs across 353 transactions between 2009 and 2011 and found meaningful risk premiums associated with non-systematic mortality risk, with calculated IRRs generally in the high single-digit to mid-teens range depending on the policy and underwriting assumptions used.
A key finding from that body of research: life settlements show a negative beta relative to equity markets, which is the statistical version of saying returns in this asset class don't move with stock prices. That property is one of the main reasons institutional investors allocate to the asset class — the diversification value comes from the non-correlation, not just the absolute return level.
The average multiple that sellers received over their policy's cash surrender value in 2024 across 2,699 transactions, totaling $601M in aggregate transaction value. That margin is what creates the economic room for investor returns on the buy-side. Source: LISA 2024 Market Data Collection Survey.
Why the widely-cited "11–13%" figure needs context
You'll see a lot of marketing content citing "average annualized returns of 11–13%" for life settlements. That range isn't wrong, but it's also often presented without the context that makes it useful. Those figures typically come from institutional portfolio-level IRRs, where diversification across many policies smooths out the actuarial variance at the individual-policy level. For a single-policy direct ownership investor, your realized IRR will cluster around that average only if you hold enough policies that the variance averages out, or if the specific policy you own happens to mature near its LE projection. Individual policies can and do fall outside that range in both directions.
The five variables that actually drive your return
Beyond the mechanical inputs to the IRR formula, these are the five factors I watch most carefully when evaluating whether a specific policy will deliver returns close to its projected IRR. The order here matters — the first two are the most important.
- Life expectancy accuracy. The single biggest driver of actual IRR is whether the LE projection is accurate. Policies with two independent LE reports from accredited underwriters that agree within 6–12 months have much lower variance in realized outcomes than policies with a single LE or LE reports that diverge significantly. Always verify how the LE was derived.
- Purchase price as a percentage of face value. Entry multiple is a proxy for how much cushion you have built into the deal. A policy purchased at 18% of face has more room for adverse LE experience than the same policy purchased at 28% of face. Track this ratio across every policy you evaluate — it's the quickest tell on whether you're overpaying.
- Premium schedule stability. Some policies have predictable, level premiums for decades. Others — especially older universal life policies with rising cost-of-insurance charges — have premiums that escalate significantly as the insured ages. If the premium schedule is rising fast, your projected IRR is more fragile, because every year the insured lives past LE costs you more in absolute dollars.
- Carrier financial strength. The death benefit only pays out if the issuing insurance carrier is still solvent and able to pay when the time comes. Carriers rated A+ or better by A.M. Best have historically extremely low failure rates, but the risk is not zero. For long-duration policies, the carrier rating at issuance is less important than the rating trajectory — watch for downgrades.
- Transaction and servicing costs. The returns that actually end up in your bank account are net of all transaction costs, platform fees, and ongoing servicing charges. A policy with a headline projected IRR of 11% might deliver a net IRR of 9% once you account for the full cost stack. Always ask for a fees-inclusive IRR projection, not a gross number.
How taxes affect your net return
Pre-tax IRR is what gets quoted. After-tax IRR is what you actually earn. The two can differ significantly for U.S. investors, depending on how the transaction is structured and what tax bracket you're in. The general framework for individual investors comes from IRS guidance including Revenue Ruling 2009-14 and related authority.
| Tax tier | What it covers | Tax treatment |
|---|---|---|
| Tier 1 — Basis recovery | Amount equal to your cost (purchase price + premiums paid) | Tax-free return of basis |
| Tier 2 — Ordinary income | Proceeds above basis up to the policy's cash surrender value at purchase | Ordinary income tax rates |
| Tier 3 — Capital gains | Proceeds above the tier 2 threshold, if held long-term | Long-term capital gains treatment |
For most individual investors, a meaningful portion of the eventual payout ends up in the tier 3 bucket, which is taxed favorably relative to ordinary income. High-income investors may also owe the 3.8% Net Investment Income Tax on investment income. The net effect is that the after-tax IRR on a life settlement typically runs 150–300 basis points below the pre-tax IRR for a taxable individual investor, depending on state of residence and overall income profile.
This is exactly the kind of calculation I strongly recommend working through with a qualified CPA before committing capital. Generic after-tax estimates aren't reliable because your personal tax situation has too many moving parts. If a sponsor is quoting after-tax IRR projections with confident specificity and hasn't seen your tax profile, take that with skepticism.
See vetted policies with transparent IRR analysis
Every policy on the HYV platform includes the baseline IRR, sensitivity scenarios, and a full cost disclosure so you can model your actual net return before committing capital.
Red flags in any "returns" pitch
These are the patterns I've learned to treat with suspicion whenever I see a life settlement opportunity pitched to retail or even accredited investors. If any of these appear in marketing material, pause and ask more questions before committing capital.
- Guaranteed or fixed returns. Life settlement returns are actuarially driven, not fixed. Any offering that guarantees a specific annual return is either misrepresenting the product, adding an unrelated guarantee structure that changes the risk profile, or has pricing that doesn't leave room for the actual volatility of the asset. Read the fine print on any "guarantee" carefully.
- "Up to" returns as the headline number. The phrase "up to 15%" or "returns of 800%+" references edge-case scenarios (early maturities on individual policies) as if they were typical outcomes. The baseline IRR is the number that should be in the headline. Early-maturity upside is just that — upside, not expected return.
- No LE report disclosure. If you can't see the actual LE reports (or at minimum the LE range and the underwriter names), you can't independently verify whether the projected return is realistic. Sponsors who don't disclose this are asking you to trust their summary, which is the opposite of due diligence.
- Single-policy IRR presented as portfolio return. A single policy's projected IRR doesn't account for the actuarial variance that exists at the individual-policy level. Portfolio IRR across 20+ policies has much lower variance. If a sponsor is presenting a single-policy IRR as if it were a portfolio-level expectation, they're conflating two different things.
- Projected IRR without fee disclosure. Headline IRR that doesn't deduct all fees — acquisition, management, servicing, platform — overstates what the investor will actually earn. Always request a net IRR projection that deducts all costs. The gap between gross and net can easily be 150–300 basis points.
The SEC Office of Investor Education and Advocacy Bulletin discusses return calculation assumptions and the risks to those assumptions. FINRA's investor guidance covers fair-value considerations and warning signs. The Actuarial Standard of Practice No. 48 covers the mortality assumptions underlying LE estimation — technical but authoritative for how these numbers are actually produced.
See what returns look like on live listings
View currently-available life settlement policies with complete documentation — LE reports, premium schedules, and projected IRR under baseline, faster, and extended scenarios. Transparent analysis, no guarantees.
Frequently asked questions
What is the typical annualized return on a life settlement investment?
Historical average annualized returns on life settlements have generally fallen in the 8–12% range at the portfolio level, with meaningful variance at the individual-policy level. Academic research and industry data support this range, though the figure represents pre-tax IRR before transaction costs. Actual realized returns for a single policy depend heavily on the accuracy of the life expectancy projection, purchase price, premium schedule, and carrier financial strength. Past performance does not guarantee future results, and returns are not fixed or predictable for any individual policy.
How is the IRR on a life settlement calculated?
The internal rate of return on a life settlement is the annualized rate that makes the net present value of all cash flows equal to zero. The cash flows are: the initial purchase price paid to the seller (outflow), ongoing premium payments needed to keep the policy in force (outflows), and the death benefit received when the insured passes away (inflow). The calculation is structurally similar to calculating the yield-to-maturity of a corporate bond, except that the time of maturity is uncertain — it depends on when the insured actually passes away rather than a defined maturity date.
Can life settlement returns go negative?
Yes. If the insured lives significantly longer than the projected life expectancy, the accumulated premium payments can exceed the eventual death benefit net of initial purchase cost, producing a negative return on the investment. In the worst case, if premium reserves are exhausted and the investor cannot or does not fund additional premiums, the policy lapses and the investor loses the entire invested capital. This is exactly why premium reserve structure and LE underwriting accuracy are the two most important factors to evaluate before committing capital to a specific policy.
Are life settlement returns correlated with the stock market?
Empirical research consistently shows that life settlement returns have low or even negative correlation with public equity markets. Returns are driven by the insured's actual date of death, which is a biological event independent of economic conditions. This non-correlation is one of the primary reasons institutional investors allocate to life settlements — they provide diversification benefits beyond the absolute return level. That said, the correlation is measured over large samples; individual policies still carry their own variance.
What's the difference between gross IRR and net IRR?
Gross IRR is the return calculated before any fees or transaction costs are deducted — just purchase price, premiums, and death benefit. Net IRR deducts all costs an investor actually pays: platform or broker fees, acquisition costs, servicing charges, and any management fees if the investment is held through a fund structure. The gap between gross and net can be 150–300 basis points or more depending on the fee structure. Always ask for net IRR when evaluating a specific offering, and confirm which fees are included in the calculation.
How do taxes affect net returns for individual investors?
Life settlement proceeds for an individual investor are generally taxed in a three-tier structure under IRS Revenue Ruling 2009-14 and related authority. The portion up to your basis (purchase price plus premiums paid) returns tax-free. Proceeds from basis up to the policy's original cash surrender value are generally ordinary income. Amounts above that may qualify for long-term capital gains treatment. High-income investors may also owe the 3.8% Net Investment Income Tax. Net-of-tax returns for a taxable individual investor typically run 150–300 basis points below the pre-tax IRR. This varies significantly by state and tax bracket — consult a qualified CPA.
Do life settlement returns compound?
Not in the traditional sense. A single life settlement policy produces one lump-sum cash flow at the time of maturity — the death benefit — rather than periodic interest or dividend payments that could be reinvested at the same rate. The IRR captures the equivalent annualized compounding rate, but there's no cash flow to actually reinvest during the hold period. For investors who want compounding exposure to the asset class, that typically comes from holding multiple policies maturing at different times, where proceeds from earlier maturities can be redeployed into new policies.
